Immunic Inc. (NASDAQ: IMUX) reported Q4 EPS of ($0.62), $0.53 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Immunic Inc. (IMUX) click here.